J. Whang‐Peng

J. Whang‐Peng, T. Chou, Yuh-Min Chen, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

DNA content analysis by flow cytometry and cytogenetic analysis in mycosis fungoides and Sézary syndrome.

A. Gazdar, J. Whang‐Peng, P. Bunn, 1980, The Journal of clinical investigation.

Familial occurrence of colon and uterine carcinoma and of lymphoproliferative malignancies. II. Chromosomal and immunologic abnormalities

J. Whang‐Peng, R. Herberman, R. Oldham, 1977, Cancer.

A phase I clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment

J. Whang‐Peng, A. Cheng, T. Chao, 2016, Journal of Biomedical Science.

Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma.

J. Whang‐Peng, B. Goh, M. Millward, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer

J. Whang‐Peng, C. Hsiung, S. Lo, 2004, The British journal of surgery.

Gemcitabine versus the combination of cisplatin and etoposide in patients with inoperable non-small-cell lung cancer in a phase II randomized study.

J. Whang‐Peng, R. Perng, C. Tsai, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II and pharmacokinetic study of paclitaxel therapy for unresectable hepatocellular carcinoma patients.

J. Whang‐Peng, Y. Chao, W. Lui, 1998, British Journal of Cancer.

A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan

J. Whang‐Peng, K. Yeh, Y. Chao, 2011, Cancer Chemotherapy and Pharmacology.

Modulation of cisplatin resistance in acquired-resistant nonsmall cell lung cancer cells.

J. Whang‐Peng, R. Perng, S. Lai, 1995, Oncology research.

Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: a Taiwan cooperative oncology group phase II study.

T. Hwang, J. Whang‐Peng, Hsiu‐Po Wang, 2011, International journal of radiation oncology, biology, physics.

Phase II randomized study of weekly docetaxel alone or plus UFUR treatment in non-small cell lung cancer patients who failed previous chemotherapy.

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2008, Lung cancer.

A randomized phase II study of docetaxel or vinorelbine in combination with cisplatin against inoperable, chemo-naïve non-small-cell lung cancer in Taiwan.

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2007, Lung cancer.

A Phase II Randomized Study of Paclitaxel Plus Carboplatin or Cisplatin against Chemo-Naive Inoperable Non-small Cell Lung Cancer in the Elderly

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A randomized phase II study of vinorelbine plus gemcitabine with/without cisplatin against inoperable non-small-cell lung cancer previously untreated.

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2005, Lung Cancer.

Paclitaxel plus carboplatin, compared with paclitaxel plus gemcitabine, shows similar efficacy while more cost-effective: a randomized phase II study of combination chemotherapy against inoperable non-small-cell lung cancer previously untreated.

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Erythroleukemia and other hematologic complications of intensive therapy in long‐term survivors of small cell lung cancer

J. Minna, J. Whang‐Peng, P. Bunn, 1982 .

A randomized trial of different docetaxel schedules in non-small cell lung cancer patients who failed previous platinum-based chemotherapy.

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2006, Chest.

Patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation. Data on potential cures, chronic toxicities, and late relapses after a five- to eleven-year follow-up.

R. Makuch, J. Minna, J. Whang‐Peng, 1985, Annals of internal medicine.

Gefitinib reverses chemotherapy resistance in gefitinib-insensitive multidrug resistant cancer cells expressing ATP-binding cassette family protein.

J. Whang‐Peng, Chih-Hsin Yang, Pan‐Chyr Yang, 2005, Cancer research.

The Aurora Kinases Inhibitor VE-465 is a Novel Treatment for Glioblastoma Multiforme

Chi-Ying F. Huang, J. Whang‐Peng, E. I. Chen, 2013, Oncology.

Identification of α-Enolase as an Autoantigen in Lung Cancer: Its Overexpression Is Associated with Clinical Outcomes

J. Whang‐Peng, T. Chou, Chih-Yi Chen, 2006, Clinical Cancer Research.

Salvage Therapy for Chinese Non-small Cell Lung Cancer Patients Who Failed Previous Chemotherapy

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

An analysis of cytokine status in the serum and effusions of patients with tuberculous and lung cancer.

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2001, Lung cancer.

Recessive oncogenes and chromosomal deletions in human lung cancer

J. Minna, A. Gazdar, F. Kaye, 1989 .

Phase II and pharmacokinetic study of GL331 in previously treated Chinese gastric cancer patients

J. Whang‐Peng, Y. Chao, Chew-wun Wu, 2002, Cancer Chemotherapy and Pharmacology.

Survival Outcome of Inoperable Non-Small Cell Lung Cancer Patients Receiving Conventional Dose Epirubicin and Paclitaxel as First-Line Treatment

J. Whang‐Peng, Chih-Hsin Yang, Pan‐Chyr Yang, 2005, Oncology.

A prospective study of the use of circulating markers as predictors for epidermal growth factor receptor-tyrosine kinase inhibitor treatment in pulmonary adenocarcinoma.

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2016, Cancer biomarkers : section A of Disease markers.

Phase II trial of intrapleural paclitaxel injection for non-small-cell lung cancer patients with malignant pleural effusions.

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 1998, Respiratory medicine.

Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. I. Physical, cytogenetic, and growth characteristics.

J. Whang‐Peng, I. Magrath, E. Douglass, 1980, Journal of the National Cancer Institute.

Synthesis of kappa light chains by cell lines containing an 8;22 chromosomal translocation derived from a male homosexual with Burkitt's lymphoma.

C. Croce, T. Triche, J. Whang‐Peng, 1983, Science.

Palliative MEFLEP Therapy in Advanced Pancreatic Cancer: Excellent Response in a Patient with Her-2/neu Amplification

J. Whang‐Peng, Y. Chao, A. Li, 2002, Pancreas.

Chromosomal aberrations in two cases of inherited aplastic anemia with unusual clinical features.

J. Whang‐Peng, J. G. Abuelo, N. R. Shulman, 1969, Annals of internal medicine.

Spider angiomas in patients with liver cirrhosis: role of vascular endothelial growth factor and basic fibroblast growth factor.

J. Whang‐Peng, Shinn-Jang Hwang, F. Chang, 2003, World journal of gastroenterology.

Elevation of interleukin-10 levels in malignant pleural effusion.

J. Whang‐Peng, R. Perng, W. Yang, 1996, Chest.

Antcin B and its ester derivative from Antrodia camphorata induce apoptosis in hepatocellular carcinoma cells involves enhancing oxidative stress coincident with activation of intrinsic and extrinsic apoptotic pathway.

Chi-Ying F. Huang, S. Shyue, J. Whang‐Peng, 2011, Journal of agricultural and food chemistry.

Chromosomal characteristics of malignant lymphoma in northern pike (Esox lucius) from the United States.

J. Whang‐Peng, C. Dawe, R. Sonstegard, 1976, Cancer research.

Chromosome 3P in small cell lung cancer

J. Minna, S. Naylor, A. Gazdar, 1988 .

SECOND MALIGNANCIES COMPLICATING HODGKIN'S DISEASE IN REMISSION

J. Whang‐Peng, V. Devita, J. Arseneau, 1975, The Lancet.

Conversion of a stem cell leukemia from a T-lymphoid to a myeloid phenotype induced by the adenosine deaminase inhibitor 2'-deoxycoformycin.

B. Haynes, J. Whang‐Peng, J. Kurtzberg, 1984, Proceedings of the National Academy of Sciences of the United States of America.

Expression of epidermal growth factor receptor in head and neck cancers correlates with clinical progression: a multicentre immunohistochemical study in the Asia–Pacific region

C. S. Lee, J. Whang‐Peng, T. Putti, 2002, Histopathology.

Frequent detection of aberrant RNA transcripts of the CDKN2 gene in human gastric adenocarcinoma

J. Whang‐Peng, Jan-Gowth Chang, P. Chen, 1997, International journal of cancer.

Examination of human tumors for rhoA mutations.

W. Linehan, J. Gnarra, Y. Weng, 1994, Oncogene.

Cross sectional study of use of alternative medicines in Chinese cancer patients.

J. Whang‐Peng, T. Chiou, J. M. Liu, 1997, Japanese journal of clinical oncology.

Hyperthermia potentiates doxorubicin-related cardiotoxic effects.

W. Schuette, D. Lees, J. Whang‐Peng, 1979, JAMA.

The effect of daunomycin on human cells in vivo and in vitro

J. Adamson, J. Whang‐Peng, S. Perry, 1969, Cancer.

Generation of Carcinoembryonic Antigen (CEA)-Specific T-Cell Responses in HLA-A*0201 and HLA-A*2402 Late-Stage Colorectal Cancer Patients after Vaccination with Dendritic Cells Loaded with CEA Peptides

J. Whang‐Peng, A. Cheng, Li‐Tzong Chen, 2004, Clinical Cancer Research.

Mitomycin-C induced hemolytic uremic syndrome: a case report and literature review.

J. Whang‐Peng, D. C. Wu, L. Chen, 1997, Japanese journal of clinical oncology.

Transcription factors and recessive oncogenes in the pathogenesis of human lung cancer

J. Minna, A. Gazdar, A. Gazdar, 1989, International journal of cancer. Supplement = Journal international du cancer. Supplement.

Phase II study with gemcitabine, ifosfamide and cisplatin in advanced non-small cell lung cancer.

J. Whang‐Peng, R. Perng, C. Tsai, 2000, Lung cancer.

A phase II trial of tamoxifen, ifosfamide, epirubicin, and cisplatin combination chemotherapy for inoperable non-small-cell lung cancer.

J. Whang‐Peng, R. Perng, C. Tsai, 2000, American journal of clinical oncology.

Phase II Study of Gemcitabine and Vinorelbine Combination Chemotherapy in Patients With Non–Small-Cell Lung Cancer Not Responding to Previous Chemotherapy

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2003, American journal of clinical oncology.

Cytogenetic study of two cases with lymphoma of mucosa-associated lymphoid tissue.

E. Jaffe, P. Duffey, M. Raffeld, 1994, Cancer genetics and cytogenetics.

Subcutaneous Panniculitis Like T Cell Lymphoma Complicated with Hemophagocytic Lymphohistiocytosis-A Case Report

J. Whang‐Peng, T. Chiou, Hsiao-Mei Chao, 2020 .

Report on essential thrombocythemia.

J. Whang‐Peng, 1981, Cancer genetics and cytogenetics.

Absence of hereditary p53 mutations in 10 familial leukemia pedigrees.

J. Fraumeni, J. Whang‐Peng, C. Felix, 1992, The Journal of clinical investigation.

Cytogenetic abnormalities in patients with cutaneous T-cell lymphomas.

J. Minna, A. Gazdar, J. Whang‐Peng, 1979, Cancer treatment reports.

Cytogenetic studies in human T-cell lymphoma virus (HTLV)-positive leukemia-lymphoma in the United States.

W. Blattner, E. Jaffe, E. Gelmann, 1985, Journal of the National Cancer Institute.

Cytogenetic studies in acute myelocytic leukemia with special emphasis on the occurrence of Ph1 chromosome.

J. Gart, J. Whang‐Peng, T. Knutsen, 1970, Blood.

CYTOGENETICALLY ABNORMAL CELL S IN VITRO IN ACUTE LEUKÆMIA

J. Whang‐Peng, P. Carbone, M. J. Duttera, 1972 .

Chromosomal abnormalities in acute lymphoblastic leukemia: structural and numerical changes in 234 cases.

J. Whang‐Peng, 1981, Cancer genetics and cytogenetics.

Sister chromatid exchanges and chromosomes in chronic myelogenous leukemia and cancer families

L. Pickle, M. Greene, J. Whang‐Peng, 1979, International journal of cancer.

Deletion of 3(p14p23) in secondary erythroleukemia arising in long-term survivors of small cell lung cancer.

D. Longo, J. Whang‐Peng, J. Minna, 1988, Journal of the National Cancer Institute.

Multiple childhood osteosarcomas in an american indian family with erythroid macrocytosis and skeletal anomalies

J. Whang‐Peng, H. Gralnick, J. Mulvihill, 1977, Cancer.

3p deletion and small cell lung carcinoma.

J. Whang‐Peng, 1989, Mayo Clinic proceedings.

Continuous infusion cisplatin and etoposide chemotherapy for cancer of unknown primary site (CUPS) in Taiwan, a region with a high prevalence of endemic viral infections.

J. Whang‐Peng, L. Chen, J. M. Liu, 1998, Japanese journal of clinical oncology.

Double signal stimulation was required for full recovery of the autologous tumor-killing effect of effusion-associated lymphocytes.

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2002, Chest.

Lymphoid blast crises of chronic myelogenous leukemia represent stages in the development of B-cell precursors.

T. Waldmann, S. Korsmeyer, J. Whang‐Peng, 1983, The New England journal of medicine.

Concurrent delivery of tumor antigens and activation signals to dendritic cells by irradiated CD40 ligand-transfected tumor cells resulted in efficient activation of specific CD8+ T cells

J. Whang‐Peng, Li Lu, Ko-Jiunn Liu, 2004, Cancer Gene Therapy.

Serum cytokine level fluctuations in chemotherapy-induced myelosuppression.

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 1996, Japanese journal of clinical oncology.

Chromosome analysis guidelines - preliminary report

F. Hecht, J. Whang‐Peng, F. Mitelman, 2016 .

A family with acute leukemia, hypoplastic anemia and cerebellar ataxia: association with bone marrow C-monosomy.

J. Whang‐Peng, G. Vawter, F. Li, 1978, The American journal of medicine.

A phase-I trial of systemic heat and adriamycin (A)

D. Lees, J. Whang‐Peng, J. Bull, 1979 .

Translocation of c-sis protooncogene in peripheral neuroepithelioma.

M. Israel, J. Whang‐Peng, C. Thiele, 1987, Cancer genetics and cytogenetics.

Genes, Fragile Sites, Chromosomal Translocations, and Cancer in Aging

J. Whang‐Peng, T. Knutsen, C. Kao-Shan, 1985 .

Mutations in dominant and recessive oncogenes, and the expression of opioid and nicotine receptors in the pathogenesis of lung cancer

S. Steinberg, J. Minna, A. Gazdar, 1991 .

Rh mosaicism and aberrant MNSs antigen expression in a patient with chronic myelogenous leukemia.

J. Whang‐Peng, A. Bracey, M. Mcginniss, 1983, American journal of clinical pathology.

Phase II study of tamoxifen, ifosfamide, epirubicin and cisplatin combination chemotherapy in patients with non-small cell lung cancer failing previous chemotherapy.

J. Whang‐Peng, R. Perng, C. Tsai, 2000, Lung cancer.

Cytogenetic studies in subgroups of rhabdomyosarcoma

T. Triche, J. Whang‐Peng, T. Knutsen, 1992, Genes, chromosomes & cancer.

Paclitaxel-induced severe neuropathy in patients with previous radiotherapy to the head and neck region.

J. Whang‐Peng, L. Chen, J. M. Liu, 1996, Journal of the National Cancer Institute.

Significance of chromosomal changes in patients of different age groups with acute leukemia.

J. Whang‐Peng, 1993, Advances in experimental medicine and biology.

A myelodysplastic syndrome with marrow eosinophilia terminating in acute nonlymphocytic leukemia, associated with an abnormal chromosome 16.

J. Whang‐Peng, S. Abbondanzo, R. Jacobson, 1987, Archives of Pathology & Laboratory Medicine.

Cytogenetically abnormal cells in vitro in acute leukaemia.

J. Whang‐Peng, P. Carbone, M. J. Duttera, 1972, Lancet.

Fatal hypereosinophilia with chromosome 15q- in a patient with multiple primary and familial neoplasms.

T. Triche, J. Whang‐Peng, J. Mulvihill, 1983, Cancer genetics and cytogenetics.

Cytogenetic studies in 45 patients with acute lymphocytic leukemia.

J. Whang‐Peng, E. Freireich, E. Frei, 1969, Journal of the National Cancer Institute.

alpha-fetoprotein response predicts survival benefits of thalidomide in advanced hepatocellular carcinoma.

J. Whang‐Peng, J. Chang, Y. Chao, 2005, Alimentary pharmacology & therapeutics.

Cytogenetic studies in polycythemia vera.

B. Modan, K. Hirschhorn, J. Whang‐Peng, 1976, Seminars in hematology (Print).

Hematologic and cytogenetic remission of blastic transformation in chronic granulocytic leukemia.

J. Whang‐Peng, V. Devita, P. Carbone, 1971, Blood.

Cytogenetic studies in patients with myelofibrosis and myeloid metaplasia

J. Whang‐Peng, A. Nienhuis, T. Knutsen, 1978 .

Ultraviolet light-induced sister chromatid exchanges in xeroderma pigmentosum and in Cockayne's syndrome lymphocyte cell lines.

J. Whang‐Peng, R. Tarone, J. Robbins, 1978, Cancer research.

In vitro evaluation of GL331's cancer cell killing and apoptosis-inducing activity in combination with other chemotherapeutic agents

J. Whang‐Peng, Li‐Tzong Chen, Chun-chung Lee, 2000, Apoptosis.

Prospective staging evaluation of patients with cutaneous T-cell lymphomas. Demonstration of a high frequency of extracutaneous dissemination.

J. Minna, A. Gazdar, J. Whang‐Peng, 1980, Annals of internal medicine.

Chemotherapy with etoposide, doxorubicin, cisplatin, 5-fluorouracil, and leucovorin for patients with advanced hepatocellular carcinoma

J. Whang‐Peng, F. Chang, Shou-Dong Lee, 2008, Medical oncology.

The Transplacental Passage of Fetal Leukocytes into the Maternal Blood

J. Whang‐Peng, S. Leikin, C. Harris, 1973, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Characterization of a suppressor-cell leukemia. Evidence for the requirement of an interaction of two T cells in the development of human suppressor effector cells.

T. Waldmann, J. Whang‐Peng, S. Broder, 1978, The New England journal of medicine.

Cytogenetic studies and clinical implications in patients with Sézary syndrome

J. Whang‐Peng, T. Knutsen, M. Lutzner, 1976, Cancer.

Cytogenetic studies of the somatic and germ-line cells in sand rats (Psammomys obesus)

J. Whang‐Peng, P. Ming, 1970, Diabetologia.

Acute non‐lymphocytic leukemia and acute myeloproliferative syndrome following radiation therapy for non‐hodgkin's lymphoma and chronic lymphocytic leukemia. Cytogenetic studies

J. Whang‐Peng, H. Brereton, T. Knutsen, 1979, Cancer.

Testicular feminization syndrome in three sibs: emphasis on gonadal neoplasia

J. Whang‐Peng, H. Ramsey, P. Wiernik, 1973, The American journal of the medical sciences.

Cells From Patients With Chronic Myelocytic Leukemia Cell Cycle Characteristics, Maturation, and Phagocytosis In Vitro of Blast

J. Gart, J. Whang‐Peng, S. Perry, 2011 .

Cell Cycle Characteristics, Maturation, and Phagocytosis In Vitro of Blast Cells From Patients With Chronic Myelocytic Leukemia

J. Gart, J. Whang‐Peng, S. Perry, 1971 .

Small F chromosome in myelo- and lymphoproliferative diseases

J. Whang‐Peng, H. Gralnick, H. Brereton, 1977 .

Cytogenetic studies in acute lymphocytic leukemia: special emphasis in long-term survival.

J. Whang‐Peng, T. Knutsen, J. Ziegler, 1976, Medical and pediatric oncology.

Cytogenetic Studies in Neoplasia (Human and Animal): Implications Prognosis, and Treatment

J. Whang‐Peng, T. Knutsen, 1989 .

Polyploidy in malignant melanoma

J. Whang‐Peng, T. Knutsen, P. Chretien, 1970, Cancer.

Cytogenetic findings in erythroleukemia.

J. Whang‐Peng, C. Heath, J. Bennett, 1969, Blood.

Clinical implications of cytogenetic variants in chronic myelocytic leukemia (CML).

J. Whang‐Peng, P. Carbone, G. Canellos, 1968, Blood.

Leukemoid reaction resulting from multiple cytokine production in metastatic mucoepidermoid carcinoma with central necrosis.

J. Whang‐Peng, R. Perng, J. M. Liu, 1995, Japanese journal of clinical oncology.

Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors.

J. Whang‐Peng, R. Ozols, T. Hamilton, 1983, Cancer research.

Diagnostic and biological implications of flow cytometric DNA content analysis in lung cancer.

A. Gazdar, J. Whang‐Peng, P. Bunn, 1983, Cancer research.

Chromosome translocation in peripheral neuroepithelioma.

M. Israel, T. Triche, J. Whang‐Peng, 1984, The New England journal of medicine.

Randomised clinical trial: comparison of two everolimus dosing schedules in patients with advanced hepatocellular carcinoma

J. Whang‐Peng, W. Su, J. Chang, 2013, Alimentary pharmacology & therapeutics.

Chronic granulocytic leukemia (CGL) during the course of chronic lymphocytic leukemia (CLL): correlation of blood, marrow, and spleen morphology and cytogenetics.

J. Whang‐Peng, H. Gralnick, R. Johnson, 1974, Blood.

Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients.

J. Whang‐Peng, C. Hsiung, C. Wen, 2005, World journal of gastroenterology.

Abnormalities in structure and expression of the human retinoblastoma gene in SCLC.

J. Minna, A. Gazdar, A. Gazdar, 1988, Science.

PIK3CA as an oncogene in cervical cancer

Chen-Yang Shen, J. Whang‐Peng, Yu-chen Lin, 2000, Oncogene.

A nonrandom chromosomal abnormality, del 3p(14-23), in human small cell lung cancer (SCLC).

J. Minna, A. Gazdar, J. Whang‐Peng, 1982, Cancer genetics and cytogenetics.

Chromosomal aberrations of malignant pleural effusions of lung adenocarcinoma: different cytogenetic changes are correlated with genders and smoking habits.

Chi-Ying F. Huang, Chi-Hung Lin, J. Whang‐Peng, 2007, Lung cancer.

Development of a second clonally discrete Burkitt's lymphoma in a human immunodeficiency virus-positive homosexual patient.

E. Jaffe, J. Whang‐Peng, I. Magrath, 1988, Blood.

Burkitt's lymphoma in AIDS: cytogenetic study.

J. Whang‐Peng, I. Magrath, H. Sieverts, 1984, Blood.

Cytogenetic studies in non-African Burkitt lymphoma.

J. Whang‐Peng, I. Magrath, E. Douglass, 1980, Blood.

Cytogenetic studies of human breast cancer lines: MCF-7 and derived variant sublines.

J. Whang‐Peng, K. Seibert, M. Lippman, 1983, Journal of the National Cancer Institute.

Translocation t(11;22) in esthesioneuroblastoma.

A. Gazdar, J. Whang‐Peng, T. Knutsen, 1987, Cancer genetics and cytogenetics.

Cytogenetic studies in ovarian cancer.

J. Whang‐Peng, R. Ozols, T. Knutsen, 1984, Cancer genetics and cytogenetics.

Cytogenetic characterization of selected small round cell tumors of childhood.

M. Israel, T. Triche, J. Whang‐Peng, 1986, Cancer genetics and cytogenetics.

Molecular genetic characterization of neuroendocrine lung cancer cell lines.

F. Kaye, H. Brauch, B. Zbar, 1995, Anticancer research.

Retention of chromosome 3 in extrapulmonary small cell cancer shown by molecular and cytogenetic studies.

S. Naylor, A. Gazdar, H. Brauch, 1989, Journal of the National Cancer Institute.

Circulation of donor lymphocytes after blood transfusion in man.

J. Whang‐Peng, G. Schechter, W. Mcfarland, 1977, Blood.

Cytogenetic Studies in Non-African

J. Whang‐Peng, I. Magrath, E. Douglass, 2017 .

Cytogenetics of human small cell lung cancer.

J. Whang‐Peng, E. Lee, 1985, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Paradoxical effect of GM‐CSF gene transfer on the tumorigenicity and immunogenicity of murine tumors

J. Whang‐Peng, Yuh-Min Chen, Yili Yang, 1998, International journal of cancer.

Clinical significance of chromosomal abnormalities in acute lymphoblastic leukemia

J. Whang‐Peng, 1981 .

Erlotinib has better efficacy than gefitinib in adenocarcinoma patients without EGFR-activating mutations, but similar efficacy in patients with EGFR-activating mutations.

J. Whang‐Peng, C. Chiu, Yuh-Min Chen, 2012, Experimental and therapeutic medicine.

First-line Systemic Therapy for Metastatic Non-small-cell Lung Cancer – A Review

J. Whang‐Peng, Yuh-Min Chen, Chien-Ming Chen, 2011 .

Cytogenetic studies of esophageal carcinoma cell lines.

J. Whang‐Peng, S. Banks-Schlegel, E. Lee, 1990, Cancer genetics and cytogenetics.

Chromosomal abnormalities and their clinical significance in acute lymphoblastic leukemia. Third International Workshop on Chromosomes in Leukemia.

C. Bloomfield, J. Rowley, J. Whang‐Peng, 1983, Cancer research.

Clinical implications of cytogenetic studies in cutaneous t‐cell lymphoma (CTCL)

J. Minna, J. Whang‐Peng, P. Bunn, 1982, Cancer.

Chemotherapy of the blastic phase of chronic granulocytic leukemia: hypodiploidy and response to therapy.

J. Whang‐Peng, V. Devita, P. Schein, 1976, Blood.

Blast crisis of chronic granulocytic leukemia. Morphologic variants and therapeutic implications.

J. Whang‐Peng, H. Gralnick, G. Canellos, 1977, The American journal of medicine.

Chronic granulocytic leukemia without the Philadelphia chromosome.

J. Whang‐Peng, V. Devita, G. Canellos, 1976, American journal of clinical pathology.

Serial cytogenetic studies of nonendemic Burkitt's lymphoma cell lines.

J. Whang‐Peng, I. Magrath, E. Douglass, 1980, Journal of the National Cancer Institute.

Sequential analysis of 43 patients with non-Hodgkin's lymphoma: clinical correlations with cytogenetic, histologic, immunophenotyping, and molecular studies.

S. Steinberg, E. Jaffe, P. Duffey, 1995, Blood.

immunodeficiency virus-positive homosexual patient Development of a second clonally discrete Burkitt's lymphoma in a human

E. Jaffe, J. Whang‐Peng, I. Magrath, 2012 .

8 – Direct Chromosome Preparation of Bone Marrow Cells*

J. Whang‐Peng, J. Tjio, 1974 .

Cytogenetic studies in patients with secondary leukemia/dysmyelopoietic syndrome after different treatment modalities.

D. Longo, J. Whang‐Peng, V. Devita, 1988, Blood.

Loss of terminal deoxynucleotidyl transferase (TDT) activity as a predictor of emergence of resistance to chemotherapy in a case of chronic myelogenous leukemia in blast crisis

J. Whang‐Peng, D. Ross, P. Sarin, 1979, Cancer.

Acute lymphoblastic leukemia followed by chronic myelocytic leukemia.

J. Whang‐Peng, A. Levine, G. Tosato, 1978, Blood.

Philadelphia-chromosome-positive preleukaemic state.

J. Whang‐Peng, G. Canellos, 1972, Lancet.

Clones in Bone Marrow ofa Patient With Paroxysmal Nocturnal Hemoglobinuria ( PNH )

J. Whang‐Peng, T. Knutsen, B. Leventhal, 2005 .

Cytogenetic studies of 21 patients with acute lymphoblastic leukemia in relapse.

C. Bloomfield, J. Rowley, A. de la Chapelle, 1989, Cancer genetics and cytogenetics.

Renal cell carcinoma. Cytogenetic analysis of tumors and cell lines.

W. Linehan, J. Gnarra, S. Liu, 1995, Cancer genetics and cytogenetics.

Phase I and pharmacokinetic study of oral thalidomide in patients with advanced hepatocellular carcinoma

J. Whang‐Peng, Y. Chao, Jang-Yang Chang, 2006, Cancer Chemotherapy and Pharmacology.

Quality of life after curative gastrectomy for gastric cancer in a randomised controlled trial

Jeng-Min Chiou, J. Whang‐Peng, S. Lo, 2008, British Journal of Cancer.

Complications Following D3 Gastrectomy: Post Hoc Analysis of a Randomized Trial

J. Whang‐Peng, S. Lo, W. Lui, 2005, World Journal of Surgery.

A randomised phase II study of weekly paclitaxel or vinorelbine in combination with cisplatin against inoperable non-small-cell lung cancer previously untreated

J. Whang‐Peng, R. Perng, J. Shih, 2004, British Journal of Cancer.

Phase II Study of Docetaxel and Gemcitabine Combination Chemotherapy in Non–Small-Cell Lung Cancer Patients Failing Previous Chemotherapy

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2002, American journal of clinical oncology.

Anesthetic management of whole-body hyperthermia for the treatment of cancer.

W. Schuette, D. Lees, J. Whang‐Peng, 1980, Anesthesiology.

Causes of induced hyperthermia.

W. Schuette, D. Lees, J. Whang‐Peng, 1979, Anesthesiology.

Brain metastasis features and association with tumor epidermal growth factor receptor mutation in patients with adenocarcinoma of the lung

J. Whang‐Peng, Yuh-Min Chen, Chu-Yun Huang, 2017, Asia-Pacific journal of clinical oncology.

Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor Treatment and Salvage Chemotherapy in EGFR-Mutated Elderly Pulmonary Adenocarcinoma Patients.

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2015, The oncologist.

Plasma epidermal growth factor receptor mutation analysis and possible clinical applications in pulmonary adenocarcinoma patients treated with erlotinib.

J. Whang‐Peng, T. Chou, Yuh-Min Chen, 2012, Oncology letters.

A multicenter phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (Stage IIIB/IV) non-small cell lung cancer.

J. Whang‐Peng, R. Perng, C. Tsai, 2000, Chest.

An Evaluation of Liquid‐Crystal Thermometry as a Screening Device for Intraoperative Hyperthermia

W. Schuette, D. Lees, J. Whang‐Peng, 1978, Anesthesia and analgesia.

Efficacy of chemotherapy in epidermal growth factor receptor (EGFR) mutated metastatic pulmonary adenocarcinoma patients who had acquired resistance to first-line EGFR tyrosine kinase inhibitor (TKI)

J. Whang‐Peng, Yuh-Min Chen, Yu-chin Lee, 2016, Journal of chemotherapy.

The epidermal growth factor receptor‐tyrosine kinase inhibitor era has changed the causes of death of patients with advanced non‐small‐cell lung cancer

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2013, Journal of the Chinese Medical Association : JCMA.

Critical Appraisal of Gefitinib in the Treatment of Non-Small Cell Lung Cancer

J. Whang‐Peng, Yuh-Min Chen, Yu-chin Lee, 2015 .

Erlotinib or Chemotherapy in Second-Line or Later Treatment of Tumor EGFR Wild-Type Pulmonary Adenocarcinoma Patients

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2015 .

Interleukin-7 and interleukin-12 have different effects in rescue of depressed cellular immunity: comparison of malignant and tuberculous pleural effusions.

J. Whang‐Peng, R. Perng, C. Tsai, 2001, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

nocturnal hemoglobinuria (PNH) Acquired XO/XY clones in bone marrow of a patient with paroxysmal

J. Whang‐Peng, T. Knutsen, B. Leventhal, 2011 .

Acquired XO/XY clones in bone marrow of a patient with paroxysmal nocturnal hemoglobinuria (PNH).

J. Whang‐Peng, T. Knutsen, B. Leventhal, 1976, Blood.

A pilot clinical trial of vaccination with dendritic cells pulsed with autologous tumor cells derived from malignant pleural effusion in patients with late‐stage lung carcinoma

J. Whang‐Peng, G. Chang, Ko-Jiunn Liu, 2005, Cancer.

Chromosomal instability in ataxia telangiectasia.

J. Whang‐Peng, W. Levis, P. Kohn, 1982, Cancer genetics and cytogenetics.

Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.

J. J. Tai, J. Whang‐Peng, Hsiu‐Po Wang, 2005, Journal of the National Cancer Institute.

Microsatellite instability in sporadic‐colon‐cancer patients with and without liver metastases

J. Whang‐Peng, Wen-Kuang Yang, Wen-chang Lin, 1997, International journal of cancer.

Acute megakaryoblastic leukemia in childhood

E. Jaffe, J. Whang‐Peng, H. Gralnick, 1984, Cancer.

A Phase I Study of Weekly Docetaxel, 24-Hour Infusion of High-Dose Fluorouracil/Leucovorin and Cisplatin in Patients with Advanced Gastric Cancer

J. Whang‐Peng, Jang-Yang Chang, T. Liu, 2002, Oncology.

Induced Pluripotent Stem Cell–conditioned Medium Suppressed Melanoma Tumorigenicity Through the Enhancement of Natural-Killer Cellular Immunity

J. Whang‐Peng, S. Chiou, Yuh-Min Chen, 2016, Journal of immunotherapy.

Genesis of the Ph1 Chromosome

J. Whang‐Peng, T. Knutsen, Elaine C. Lee, 1974 .

Long-Term Results of a Randomized, Observation-Controlled, Phase III Trial of Adjuvant Interferon Alfa-2b in Hepatocellular Carcinoma After Curative Resection

L. Jeng, J. Whang‐Peng, Po-Huang Lee, 2012, Annals of surgery.

Dicentric isochromosome for the long arm of chromosome #17, dic i(17q), in a patient with chronic myelogenous leukemia (CML).

J. Whang‐Peng, T. Knutsen, D. Solanki, 1981, Cancer genetics and cytogenetics.

Cytogenic studies in metastatic neuroblastoma.

J. Whang‐Peng, J. Bennett, 1968, American journal of diseases of children.

Nephrotic syndrome associated with a clonal T-cell leukemia of large granular lymphocytes with cytotoxic function.

J. Whang‐Peng, G. Schechter, R. Schulof, 1986, Archives of internal medicine.

T‐Cell Lymphoblastic Lymphoma With Eosinophilia Associated With Subsequent Myeloid Malignancy

E. Jaffe, J. Whang‐Peng, L. Medeiros, 1992, The American journal of surgical pathology.

Leukemia (CML) Clinical Implications of Cytogenetic Variants in Chronic Myelocytic

J. Whang‐Peng, P. Carbone, G. Canellos, 2011 .

Development and Validation of an Instrument for the Measurement of Health-Related Quality of Life Based on View of Traditional Chinese Medicine Perspective

J. Whang‐Peng, W. Chie, Hen-Hong Chang, 2012, Journal of Traditional and Complementary Medicine.

Non-surgical treatment for afferent loop syndrome in recurrent gastric cancer complicated by peritoneal carcinomatosis: percutaneous transhepatic duodenal drainage followed by 24-hour infusion of high-dose fluorouracil and leucovorin.

J. Whang‐Peng, J. Chang, J-Y Chang, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Hematuria induced by combination regorafenib and hyperthermia – a radiation recall effect

J. Whang‐Peng, G. Lai, J. Chow, 2019, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Methodologic advances in the cytogenetic analysis of human solid tumors.

J. Whang‐Peng, S. Pathak, A. Goodacre, 1986, Cancer genetics and cytogenetics.

Lymphocytic leukaemias, acute and chronic.

J. Whang‐Peng, T. Knutsen, 1980, Clinics in haematology.

Stage migration influences on stage-specific survival comparison between D1 and D3 gastric cancer surgeries.

J. Whang‐Peng, C. Hsiung, S. Lo, 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Phase II study of megestrol acetate in the treatment of hepatocellular carcinoma

J. Whang‐Peng, Shou-Dong Lee, Y. Chao, 1997, Journal of gastroenterology and hepatology.

Metastatic nasopharyngeal carcinoma with epidural spinal cord compression: report of an unusual and catastrophic event.

J. Whang‐Peng, J. M. Liu, Y. Chen, 1995, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed.

Guinea pig leukemia L2C: characterization of chromosomes and attempts to demonstrate antigenicity.

B. Zbar, J. Whang‐Peng, H. Rapp, 1970, Journal of the National Cancer Institute.

A phase II study of carboplatin in nasopharyngeal carcinoma.

J. Whang‐Peng, S. Lo, C. Shu, 1997, Oncology.

PD‐L1 Expression of Tumor Cells, Macrophages, and Immune Cells in Non–Small Cell Lung Cancer Patients with Malignant Pleural Effusion

J. Whang‐Peng, T. Chou, Yuh-Min Chen, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Circulating free mitochondrial DNA concentration and its association with erlotinib treatment in patients with adenocarcinoma of the lung

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2014, Oncology letters.

Percutaneous Transhepatic Duodenal Drainage as an Alternative Approach in Afferent Loop Obstruction with Secondary Obstructive Jaundice in Recurrent Gastric Cancer

J. Whang‐Peng, C. Tiu, Li‐Tzong Chen, 1998, CardioVascular and Interventional Radiology.

Pulmonary embolism after transcatheter arterial chemoembolization.

J. Whang‐Peng, J. Chang, J. M. Liu, 2005, European journal of cancer care.

Dicentric Ph1 chromosome.

J. Whang‐Peng, T. Knutsen, E. Lee, 1973, Journal of the National Cancer Institute.

Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer

T. Hwang, J. Whang‐Peng, Hsiu‐Po Wang, 2009, Cancer Chemotherapy and Pharmacology.

Regulation of core body temperature during whole body hyperthermia by oesophageal temperature feedback

W. Schuette, D. Lees, J. Whang‐Peng, 1980, Medical and Biological Engineering and Computing.

Phase II study of flutamide in the treatment of hepatocellular carcinoma

J. Whang‐Peng, Y. Chao, Sung-Sang Wang, 1996, Cancer.

Weekly CAF chemotherapy for advanced breast cancer patients.

J. Whang‐Peng, C. Hsiung, A. Cheng, 1997, Oncology.

Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48‐h infusion of fluorouracil/leucovorin for advanced pancreatic cancer

J. Whang‐Peng, Chiun Hsu, Hsiu‐Po Wang, 2006, Journal of gastroenterology and hepatology.

Preliminary report of a randomized trial of different docetaxel schedules in non-small cell lung cancer patients failing previous chemotherapy.

J. Whang‐Peng, R. Perng, J. Shih, 2004, Journal of Clinical Oncology.

hypodiploidy and response to therapy Chemotherapy of the blastic phase of chronic granulocytic leukemia

J. Whang‐Peng, G. Canellos, 2011 .

Effect of Age on Pulmonary Metastases and Immunotherapy in Young and Middle‐aged Mice

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2007, Journal of the Chinese Medical Association : JCMA.

Effect of age on tumor metastases and immunotherapy than the middle-aged mice after IV of B 16 melanoma cells

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2007 .

Clinical Development and Future Direction for the Treatment of Hepatocellular Carcinoma

J. Whang‐Peng, Chiun Hsu, A. Cheng, 2010 .

Chemotherapy for non-small cell lung cancer in elderly patients.

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2005, Chest.

Third‐line or fourth‐line chemotherapy in non‐small‐cell lung cancer patients with relatively good performance status

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2011, Journal of the Chinese Medical Association : JCMA.

Phase I–II trial of weekly gemcitabine plus high‐dose 5‐fluorouracil and leucovorin in advanced pancreatic cancer

J. Whang‐Peng, Chih-Hung Hsu, Y. Chao, 2006, Journal of gastroenterology and hepatology.

LONG‐TERM COMPLETE REMISSION OF METASTATIC GASTRIC CANCER AFTER WEEKLY DOCETAXEL, 24 H INFUSION OF HIGH‐DOSE 5‐FU/LEUCOVORIN AND CISPLATIN

J. Whang‐Peng, Jang-Yang Chang, T. Liu, 2005, Journal of gastroenterology and hepatology.

Phase II study of ifosfamide and etoposide chemotherapy for extensive-disease small-cell lung cancer.

J. Whang‐Peng, R. Perng, C. Tsai, 1997, Japanese journal of clinical oncology.

The Association Between Tumor Epidermal Growth Factor Receptor (EGFR) Mutation and Multiple Primary Malignancies in Patients With Adenocarcinoma of the Lungs

J. Whang‐Peng, T. Chou, C. Chiu, 2015, American journal of clinical oncology.

Isopentenyladenosine Stimulates and Inhibits Mitosis of Human Lymphocytes Treated with Phytohemagglutinin

J. Whang‐Peng, S. Perry, R. Gallo, 1969, Science.

Managing the transition in cervical screening methods for Taiwan: Policy recommendations and perspectives

J. Whang‐Peng, G. Lai, R. Pwu, 2023, Journal of the Formosan Medical Association.

A pharmacokinetic study with the high-dose anticancer agent menadione in rabbits.

J. Whang‐Peng, F. Wu, C. Wu, 1996, Biopharmaceutics & drug disposition.

Cytogenetics of non-hodgkin's lymphomas

J. Whang‐Peng, T. Knutsen, 1997 .

Direct cytogenetic studies by needle aspiration of Burkitt's lymphoma in Ghana, West Africa.

J. Whang‐Peng, R. Biggar, F. Nkrumah, 1981, Journal of the National Cancer Institute.

Restoration of the Immunocompetence by IL‐2 Activation and TCR‐CD3 Engagement of the In Vivo Anergized Tumor‐Specific CTL from Lung Cancer Patients

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 1997, Journal of immunotherapy.

A Phase II Randomized Trial of Gefitinib Alone or with Tegafur/Uracil Treatment in Patients with Pulmonary Adenocarcinoma Who had Failed Previous Chemotherapy

J. Whang‐Peng, T. Chou, Yuh-Min Chen, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Banding in leukemia: techniques and implications.

J. Whang‐Peng, 1977, Journal of the National Cancer Institute.

The status of the do-not-resuscitate order in Chinese clinical trial patients in a cancer centre.

J. Whang‐Peng, Yuh-Min Chen, L. Chen, 1999, Journal of medical ethics.

Peripheral neuroepithelioma: genetic analysis of tumor derived cell lines.

M. Israel, T. Triche, J. Whang‐Peng, 1985, Progress in clinical and biological research.

Adjuvant Therapy for Thymic Carcinoma – A Decade of Experience in a Taiwan National Teaching Hospital

J. Whang‐Peng, Yuh-Min Chen, Yu-Chung Wu, 2016, PloS one.

Transplantable hepatomas induced in strain-2 guinea pigs by diethylnitrosamine: characterization by histology, growth, and chromosomes.

B. Zbar, J. Whang‐Peng, H. Rapp, 1969, Journal of the National Cancer Institute.

Phase II randomized study of daily gefitinib treatment alone or with vinorelbine every 2 weeks in patients with adenocarcinoma of the lung who failed at least 2 regimens of chemotherapy

J. Whang‐Peng, T. Chou, Yuh-Min Chen, 2007, Cancer.

A phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (stage IIIb/IV) non-small-cell lung cancer patients aged 80 or older.

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2003, Lung cancer.

Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues.

R C Young, J. Whang‐Peng, R. Ozols, 1987, Cancer research.

Selection of DDX 5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap resampling scheme

Chi-Ying F. Huang, Chi-Hung Lin, Ching-Wei Chang, 2007 .

Unusual clonal evolution in a case of chronic myelogenous leukemia.

J. Whang‐Peng, S. Broder, R. Young, 1976, Acta Haematologica.

Culture of a cell line (NCLP-6) derived from a hepatocarcinoma induced in Macaca mulatta by N-nitrosodiethylamine.

J. Whang‐Peng, W. D. Morgan, M. Kelly, 1968, Journal of the National Cancer Institute.

Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia.

Walker, C. Bloomfield, A. de la Chapelle, 1986, Blood.

Prolonged cytogenetic and hematologic remission of blastic transformation in chronic granulogytic leukemia

J. Whang‐Peng, G. Canellos, C. Brown, 1972, Cancer.

Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemia.

C. Bloomfield, J. Rowley, A. de la Chapelle, 1989, Cancer genetics and cytogenetics.

S- and G2-phase cell cycle arrests and apoptosis induced by ganciclovir in murine melanoma cells transduced with herpes simplex virus thymidine kinase.

J. Whang‐Peng, Sung-Jen Wei, Wen-Kuang Yang, 1998, Experimental cell research.

Usage of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (EGFR-TKI) in Tumor EGFR Wild-Type or Unknown Non-Small Cell Lung Cancer

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2013 .

Microsatellite instability in sporadic‐colon‐cancer patients with and without liver metastases

J. Whang‐Peng, Wen-Kuang Yang, Wen-chang Lin, 1997, International journal of cancer.

A phase II randomized study of vinorelbine alone or with cisplatin against chemo-naïve inoperable non-small cell lung cancer in the elderly.

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2008, Lung cancer.

Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21-22.

J. Wang, C. Croce, J. Whang‐Peng, 1988, Proceedings of the National Academy of Sciences of the United States of America.

A phase I clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment

J. Whang‐Peng, A. Cheng, T. Chao, 2016, Journal of Biomedical Science.

A phase II trial of gemcitabine plus UFUR combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy.

J. Whang‐Peng, Yuh-Min Chen, R. Perng, 2006, Lung Cancer.

Establishment of human mesothelioma cell lines (MS-1, -2) and production of a monoclonal antibody (anti-MS) with diagnostic and therapeutic potential.

J. Whang‐Peng, S. Hsu, P. Hsu, 1988, Cancer research.

Clinical trials of HCC in Taiwan.

J. Whang‐Peng, Y. Chao, 1998, Hepato-Gastroenterology.

Erythroleukemia and other hematologic complications of intensive therapy in long-term survivors of small cell lung cancer.

J. Minna, J. Whang‐Peng, P. Bunn, 1982, Cancer.

myc Family oncogenes, autocrine growth factors, and chromosomal deletions in the pathogenesis of lung cancer

J. Battey, E. Sausville, S. Naylor, 1987 .

Correlations between intercalator-induced DNA strand breaks and sister chromatid exchanges, mutations, and cytotoxicity in Chinese hamster cells.

Y. Pommier, J. Whang‐Peng, L. Zwelling, 1985, Cancer research.

Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia.

J. Whang‐Peng, T. Mitsudomi, Takashi Takahashi, 1992, The Journal of clinical investigation.

So-called C marker chromosome and Epstein-Barr virus.

J. Whang‐Peng, T. Knutsen, P. Gerber, 1970, Journal of the National Cancer Institute.

Establishment of human mesothelioma cell lines (MS-1, -2) and production of a monoclonal antibody (anti-MS) with diagnostic and therapeutic potential.

J. Whang‐Peng, S. Hsu, C. Kao-Shan, 1988, Cancer research.

Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap re-sampling scheme

Chi-Ying F. Huang, Ching-Wei Chang, J. Whang‐Peng, 2007, BMC Genomics.

Reappraisal of the Early Diagnostic Value of Serial Analyses of Western Blot Patterns for HIV Infection in Neonates

Y. Ko, J. Whang‐Peng, J. Sung, 1996 .

Involvement of chromosome No. 22 in neuroblastoma

J. Whang‐Peng, E. Douglass, D. Poplack, 1980 .

Myeloproliferative syndromes: a unique presentation of chronic myelogenous leukemia (CML) as a primary tumor of bone.

E. Jaffe, D. Longo, T. Triche, 1978, Blood.

RADIATION THERAPY FOR NON-HODGKIN'S

J. Whang‐Peng, H. Brereton, T. Knutsen, 1979 .

Cutaneous T-cell Lymphoma (CTCL)

J. Whang‐Peng, G. Schechter, John D. Minna, 2006 .

Phase II randomized trial of erlotinib versus vinorelbine in chemotherapy-naive patients with advanced non-small-cell lung cancer (NSCLC) aged ≥70 years in Taiwan.

J. Whang‐Peng, R. Perng, C. Tsai, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ring chromosome in a case of acute myelomonocytic leukemia: its significance and a review of the literature.

J. Whang‐Peng, C. Kao-Shan, G. Schechter, 1987, Hematologic pathology.